Effects of PTH Replacement on Bone in Hypoparathyroidism

NCT00395538 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

46

Enrollment

NIH

Sponsor class

Stopped Pharmacy temporarily suspended by FDA

Conditions

Hypoparathyroidism
DiGeorge Syndrome

Interventions

DRUG: PTH 1-34

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)